Klotho-based therapies - Klothea Bio
Latest Information Update: 21 Jan 2025
Price :
$50 *
At a glance
- Originator Klothea Bio
- Class Antineoplastics; Obesity therapies; RNA
- Mechanism of Action Klotho protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Alzheimer's disease; Cancer; Obesity